fda warning letters compounded semaglutide tirzepatide september 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Are Compounded GLP-1s Going Away?

Pregnant women exposed to semaglutide and healthcare providers are encouraged to contact Novo Nordisk at 1-800-727-6500

For researchers evaluating whether to commit to retatrutide protocols now, the relevant comparison isnt just against existing dual agonistsits against the 2436 month pipeline of next-generation metabolic peptides that may offer superior efficacy at comparable or lower cost

Red asterisks indicate significance of GLP-1RA/Tesaglitazar over Vhcl, blue asterisks indicate significance of Tesaglitazar over Vhcl

Medications will only be prescribed after a comprehensive review and professional evaluation by our team

While this provides important baseline protection, it leaves gaps: entire drug classes that athletes could test positive for despite using "certified" products